{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T04:32:58Z","timestamp":1762057978193,"version":"build-2065373602"},"reference-count":16,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Lublin","award":["DS 410","DS 640"],"award-info":[{"award-number":["DS 410","DS 640"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Currently, data regarding the impact of COVID-19 disease (caused by SARS-CoV-2) on patients with childhood rheumatic diseases are significantly limited. To assess the possible connection, we measured levels of IgA and IgG anti-SARS-CoV-2 antibodies in children with juvenile idiopathic arthritis (JIA) and a control group during the pandemic, prior to the introduction of anti-COVID-19 vaccination. We assessed levels of PD-1 suppressive molecule and inflammatory markers in patients and correlated those results with serological response to SARS-CoV-2. In JIA patients, the activity of the disease was assessed using the Juvenile Arthritis Disease Activity Score 71 (JADAS 71) scale. The study consisted of 96 children, 65 diagnosed with JIA, treated with antirheumatic drugs, and 31 healthy volunteers. In patients with JIA, significantly higher levels of SARS-CoV-2 antibodies in the IgA and IgG were demonstrated compared to the control group. We also found significantly higher serum PD-1 levels in JIA patients and control volunteers who were seropositive for SARS-CoV-2 IgA or IgG antibodies compared to those who were seronegative. The humoral immune response to SARS-CoV-2 infection is associated with the persistent upregulation of PD-1 expression in both JIA patients and healthy children. The clinical significance of the detected disorder requires further careful observation.<\/jats:p>","DOI":"10.3390\/jcm11144060","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T22:06:00Z","timestamp":1657749960000},"page":"4060","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Programmed Cell Death Protein-1 Upregulation in Response to SARS-CoV-2 in Juvenile Idiopathic Arthritis: A Case-Control Study"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1644-5568","authenticated-orcid":false,"given":"Violetta","family":"Opoka-Winiarska","sequence":"first","affiliation":[{"name":"Department of Paediatric Pulmonology and Rheumatology, Medical University of Lublin, Gebali 6, 20-093 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0451-4741","authenticated-orcid":false,"given":"Ewelina","family":"Grywalska","sequence":"additional","affiliation":[{"name":"Department of Experimental Immunology, Medical University of Lublin, Chodzki 4a, 20-093 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1634-0387","authenticated-orcid":false,"given":"Izabela","family":"Korona-G\u0142owniak","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Microbiology, Medical University of Lublin, Chodzki 1, 20-093 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9462-8779","authenticated-orcid":false,"given":"Izabela","family":"Morawska","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Immunotherapy, Medical University of Lublin, Chodzki 4a, 20-093 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Gosik","sequence":"additional","affiliation":[{"name":"Department of Experimental Immunology, Medical University of Lublin, Chodzki 4a, 20-093 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1503-7634","authenticated-orcid":false,"given":"Anna","family":"Malm","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Microbiology, Medical University of Lublin, Chodzki 1, 20-093 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4841-6120","authenticated-orcid":false,"given":"Jacek","family":"Roli\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Immunotherapy, Medical University of Lublin, Chodzki 4a, 20-093 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41584-020-00562-2","article-title":"Rheumatic disease and COVID-19: Epidemiology and outcomes","volume":"17","author":"Hyrich","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"119124","DOI":"10.1016\/j.lfs.2021.119124","article-title":"SARS-CoV-2 infection: The role of PD-1\/PD-L1 and CTLA-4 axis","volume":"270","author":"Aghbash","year":"2021","journal-title":"Life Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12969-021-00648-5","article-title":"Clinical characteristics and COVID-19 outcomes in a regional cohort of pediatric patients with rheumatic diseases","volume":"19","author":"Clemente","year":"2021","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Opoka-Winiarska, V., Grywalska, E., Korona-Glowniak, I., Matuska, K., Malm, A., and Roli\u0144ski, J. (2021). Seroprevalence of Antibodies against SARS-CoV-2 in Children with Juvenile Idiopathic Arthritis a Case-Control Study. J. Clin. Med., 10.","DOI":"10.3390\/jcm10081771"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jbspin.2018.03.003","article-title":"Decreased PD-1 expression on circulating CD4+T cell and PD-L1 expression on myeloid dendritic cell correlate with clinical manifestations in systemic juvenile idiopathic arthritis","volume":"86","author":"Cai","year":"2019","journal-title":"Jt. Bone Spine"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12969-016-0085-5","article-title":"Clinical outcome measures in juvenile idiopathic arthritis","volume":"14","author":"Consolaro","year":"2016","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"ref_7","unstructured":"Ritchie, H., Mathieu, E., Rod\u00e9s-Guirao, L., Appel, C., Giattino, C., Ortiz-Ospina, E., Hasell, J., Macdonald, B., Beltekian, D., and Roser, M. (2022, January 22). Coronavirus Pandemic (COVID-19). OurWorldInData.org. Available online: https:\/\/ourworldindata.org\/coronavirus."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s10067-022-06067-5","article-title":"Asymptomatic SARS-CoV-2 seropositivity: Patients with childhood-onset rheumatic diseases versus healthy children","volume":"41","author":"Haslak","year":"2022","journal-title":"Clin. Rheumatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"SI112","DOI":"10.1093\/rheumatology\/keab730","article-title":"Seroprevalence and Clinical Outcomes of SARS-CoV-2 in Paediatric Patients with Rheumatic Disease","volume":"61","author":"Walters","year":"2021","journal-title":"Rheumatology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e001687","DOI":"10.1136\/rmdopen-2021-001687","article-title":"Clinical manifestations and outcome of SARS-CoV-2 infections in children and adolescents with rheumatic musculoskeletal diseases: Data from the National Paediatric Rheumatology Database in Germany","volume":"7","author":"Sengler","year":"2021","journal-title":"RMD Open"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The PD-1 pathway in tolerance and autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/pr.2015.144","article-title":"Comparison of biomarkers for systemic juvenile idiopathic arthritis","volume":"78","author":"Shenoi","year":"2015","journal-title":"Pediatr. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1172\/JCI96107","article-title":"PD-1+CD8+ T cells are clonally expanding effectors in human chronic inflammation","volume":"128","author":"Petrelli","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_14","first-page":"3297","article-title":"Elevated expression of PD-1 on T cells correlates with disease activity in rheumatoid arthritis","volume":"17","author":"Luo","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.10.025","article-title":"PD-1 immunobiology in systemic lupus erythematosus","volume":"97","author":"Curran","year":"2019","journal-title":"J. Autoimmun."},{"key":"ref_16","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: Second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J. Rheumatol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/14\/4060\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:49:52Z","timestamp":1760140192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/14\/4060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,13]]},"references-count":16,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["jcm11144060"],"URL":"https:\/\/doi.org\/10.3390\/jcm11144060","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2022,7,13]]}}}